Background: Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further IKBA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation. [SUBUNIT] Interacts with THRB (via ligand-binding domain). Interacts with RELA and REL. Interacts with COMMD1 and inhibitor kappa B-interacting Ras-like NKIRAS1 and NKIRAS2. [TISSUE SPECIFICITY] Expressed in all tissues examined. Belongs to the NF-kappa-B inhibitor family.
Description: Rabbit polyclonal to IκBβ
Immunogen: KLH conjugated synthetic peptide derived from IκBβ
Specificity: ·Reacts with Human, Mouse, and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/100-500. Predicted Mol wt: 38 kDa;
·Immunohistochemistry (Frozen/paraffin tissue section): 1/100-500;
·Immunocytochemistry: 1/100-500;
· ELISA: 1/1000;
·Optimal working dilutions must be determined by the end user.
